Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › California › Santa Monica
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Santa Monica, CA keessatti
Qorannoo 45 Kansara Qara'a Non-Small Cell f Santa Monica fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Namoota walitti qabaa jiraSadarkaa 3
- Beverly Hills Cancer Center ( Site 0116), Beverly Hills · Miili 6 fagaatti
A Study of ZW251 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of California Los Angeles - Cancer Care - Santa Monica (UCLA), Santa Monica
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Namoota walitti qabaa jiraSadarkaa 3
- Tower Cancer Research Foundation, Beverly Hills · Miili 6 fagaatti
- Cedars-Sinai Cancer - Tarzana, Tarzana · Miili 11 fagaatti
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- UCLA - Santa Monica /ID# 271690, Santa Monica
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · Miili 12 fagaatti
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Research Advisors, LLC, Beverly Hills · Miili 6 fagaatti
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Namoota walitti qabaa jiraSadarkaa 3
- Tower Cancer Research Foundation, Beverly Hills · Miili 6 fagaatti
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Santa Monica UCLA Medical Center & Orthopaedic Hospital, Santa Monica
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Namoota walitti qabaa jiraSadarkaa 3
- Beverly Hills Cancer Center, Beverly Hills · Miili 6 fagaatti
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- ALX Center 11, Santa Monica
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Santa Monica
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Namoota walitti qabaa jiraSadarkaa 3
- Beverly Hills Cancer Center ( Site 0070), Beverly Hills · Miili 6 fagaatti
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
- UCLA Medical Center, Santa Monica
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Namoota walitti qabaa jiraSadarkaa 1/2
- Precision NextGen Oncology, Beverly Hills · Miili 6 fagaatti
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Kivu Trial Site, Santa Monica
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Beverly Hills · Miili 6 fagaatti
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Namoota walitti qabaa jiraSadarkaa 3
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · Miili 6 fagaatti
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Beverly Hills · Miili 6 fagaatti
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Study Site, Beverly Hills · Miili 6 fagaatti
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Namoota walitti qabaa jiraSadarkaa 3
- Sarcoma Oncology Center, Santa Monica
- University of California Los Angeles, Santa Monica
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UCLA, Santa Monica
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1
- UCLA Health - Santa Monica Cancer Care, Santa Monica
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Santa Monica
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- UCLA - David Geffen School of Medicine, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · Miili 6 fagaatti
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of California, Los Angeles (UCLA), Santa Monica
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Cedars-Sinai Cancer at Beverly Hills (THO), Beverly Hills · Miili 6 fagaatti
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Namoota walitti qabaa jiraSadarkaa 1
- UCLA Healthcare Hematology-Oncology, Santa Monica
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Namoota walitti qabaa jiraSadarkaa 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · Miili 6 fagaatti
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UCLA Department of Medicine - Hematology & Oncology, Santa Monica
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Research Site, Santa Monica
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Sarcoma Oncology Center, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · Miili 6 fagaatti
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Tower Cancer Research Foundation, Beverly Hills · Miili 6 fagaatti
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UCLA Santa Monica Hematology Oncology, Santa Monica
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Namoota walitti qabaa jiraSadarkaa 1/2
- UCLA, Santa Monica
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Tower Cancer Research Foundation, Beverly Hills · Miili 6 fagaatti
- Cedars-Sinai Cancer - Tarzana, Tarzana · Miili 11 fagaatti
- Kaiser Permanente-Woodland Hills, Woodland Hills · Miili 12 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Tower Cancer Research Foundation, Beverly Hills · Miili 6 fagaatti
- Cedars-Sinai Cancer - Tarzana, Tarzana · Miili 11 fagaatti
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 2
- Precision NextGen Oncology and Research Center, Beverly Hills · Miili 6 fagaatti
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Namoota walitti qabaa jira
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · Miili 4 fagaatti
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site 128, Santa Monica
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Namoota walitti qabaa jiraSadarkaa 1/2
- Precision NextGen Oncology, Beverly Hills · Miili 6 fagaatti
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
Namoota walitti qabaa jiraSadarkaa 1
- Beverly Hills Cancer Center, Beverly Hills · Miili 6 fagaatti
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Precision NextGen Oncology, Beverly Hills · Miili 6 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Santa Monica keessatti
- Saree OljooQorannoo 28
- Kansarii ColorectalQorannoo 23
- Saree (Gosoota Hunda)Qorannoo 22
- Kansara MetastatikiiQorannoo 19
- Dhibee QaraQorannoo 15
- Kansarii OvariiQorannoo 15
- Kansarii ProstateQorannoo 15
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 13
- Cufama OnneeQorannoo 11
- Kansa EndometiriyaaliiQorannoo 10
- Kanisa HarkaaQorannoo 9
- Kansarii PancreasQorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.